Correction to: Nature Medicine https://doi.org/10.1038/s41591-020-0949-6, published online 5 June 2020.
In the version of this article initially published, some of the values cited were incorrect. In the second sentence of the first paragraph of the main body of text, the number of confirmed infections (420 million) was incorrect. The correct value is 4.2 million. In Table 1, the ‘Community resident’ row, the percentages for Male (56.4%), IgG+ (1.4%) and IgM+ (1.6%) were incorrect. The correct values are 47.2%, 0.3% and 0.3% (respectively). Also, in the bottom row of Table 1 (Subtotal), the percentage for Male (48.1%) was incorrect. The correct value is 47.7%. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Xu, X., Sun, J., Nie, S. et al. Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med 26, 1494 (2020). https://doi.org/10.1038/s41591-020-1058-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-1058-2
This article is cited by
-
Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats
BMC Infectious Diseases (2021)
-
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
Virologica Sinica (2020)
